3′-ethynylcytidine derivative
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 15, 2011
Grant Date -
Dec 10, 2009
app pub date -
Jul 23, 2007
filing date -
Jul 24, 2006
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
To provide a compound which exhibits excellent anti-tumor activity and excellent oral absorption and which is a useful anti-tumor drug.The invention provides a 3′-ethynylcytidine derivative represented by formula (1):each represent a (substituted) alkyl group, a (substituted) cyclic alkyl group, or a (substituted) aryl group) or a salt thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully